Status:
NOT_YET_RECRUITING
Magnesium Sulfate and Trigger Points
Lead Sponsor:
Fayoum University
Conditions:
Myofascial Pain Syndrome
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The patients will be randomly assigned to one of the two groups according to the treatment method: group I (masseter group) and group II (masseter \&sternocleidomastoid group) where each patient will ...
Eligibility Criteria
Inclusion
- definite diagnosis of myofascial pain
- presence of one or more unilateral or bilateral trigger points in the masseter muscle and sternocleidomastoid muscle;
- no history of any invasive procedures of the related masseter muscle.
Exclusion
- any painful conditions (other than myofascial trigger points) affecting the orofacial region
- any systemic diseases that could masticatory function (e.g., rheumatoid arthritis and epilepsy);
- pregnancy and lactation
Key Trial Info
Start Date :
June 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 27 2026
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06975813
Start Date
June 1 2025
End Date
January 27 2026
Last Update
May 16 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.